Quest Diagnostics Incorporated (DGX)
Automate Your Wheel Strategy on DGX
With Tiblio's Option Bot, you can configure your own wheel strategy including DGX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol DGX
- Rev/Share 91.5135
- Book/Share 63.4505
- PB 2.8869
- Debt/Equity 0.9482
- CurrentRatio 1.44
- ROIC 0.0751
- MktCap 20117743350.0
- FreeCF/Share 9.5135
- PFCF 19.0509
- PE 22.3002
- Debt/Assets 0.4159
- DivYield 0.0169
- ROE 0.1322
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | DGX | Redburn Atlantic | -- | Buy | -- | $195 | April 2, 2025 |
| Downgrade | DGX | Citigroup | Buy | Neutral | -- | $185 | March 4, 2025 |
| Upgrade | DGX | Leerink Partners | Market Perform | Outperform | $169 | $174 | Jan. 6, 2025 |
| Upgrade | DGX | Morgan Stanley | Equal Weight | Overweight | $145 | $172 | Dec. 17, 2024 |
| Resumed | DGX | Jefferies | -- | Buy | $175 | $185 | Dec. 10, 2024 |
| Upgrade | DGX | Robert W. Baird | Neutral | Outperform | $157 | $182 | Oct. 23, 2024 |
| Resumed | DGX | Evercore ISI | -- | In-line | -- | $165 | Aug. 28, 2024 |
News
Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term
Published: June 02, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
HOLX vs. DGX: Which Women's Health-Focused Stock Is the Better Pick?
Published: May 27, 2025 by: Zacks Investment Research
Sentiment: Positive
With women's health increasingly becoming a global priority, investors are actively targeting companies operating in this space to boost their portfolios. Research and Markets projects the women's health diagnostics market to expand at a compound annual rate of 9.25% through 2030, driven by technological advancements, increasing healthcare expenditures, and initiatives for early detection of women-specific conditions like reproductive health issues, breast cancer, osteoporosis and more.
Read More
What's Driving Quest Diagnostics Stock's 25.6% Rally in a Year?
Published: May 21, 2025 by: Zacks Investment Research
Sentiment: Positive
DGX has shown notable strength in the past year, driven by robust core performance and contributions from acquisitions.
Read More
Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference
Published: May 16, 2025 by: PRNewsWire
Sentiment: Neutral
SECAUCUS, N.J. , May 16, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will speak on the company's strategy, performance and the latest market developments and trends during a presentation at the William Blair 45th Annual Growth Stock Conference in Chicago on Tuesday, June 3, 2025, at 11:00 a.m.
Read More
Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock
Published: May 16, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock
Published: May 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Take the Zacks Approach to Beat the Markets: ADMA Biologics, Limbach, Quest Diagnostics in Focus
Published: May 05, 2025 by: Zacks Investment Research
Sentiment: Neutral
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Read More
These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Q1 Earnings
Published: April 23, 2025 by: Benzinga
Sentiment: Positive
Quest Diagnostics Incorporated DGX posted better-than-expected first-quarter earnings on Tuesday.
Read More
Quest Diagnostics Incorporated (DGX) Q1 2025 Earnings Call Transcript
Published: April 22, 2025 by: Seeking Alpha
Sentiment: Neutral
Quest Diagnostics Incorporated (NYSE:DGX ) Q1 2025 Results Conference Call April 22, 2025 8:30 AM ET Company Participants Shawn Bevec - Vice President of Investor Relations Jim Davis - Chairman, Chief Executive Officer, President Sam Samad - Chief Financial Officer Conference Call Participants Luke Sergott - Barclays Kevin Caliendo - UBS Patrick Donnelly - Citi Elizabeth Anderson - Evercore ISI Michael Cherny - Leerink Partners Pito Chickering - Deutsche Bank Noah Kava - Jefferies David Westenberg - Piper Sandler Michael Ryskin - Bank of America Andrew Brackmann - William Blair Jack Meehan - Nephron Research Erin Wright - Morgan Stanley …
Read More
Quest Diagnostics Q1 Earnings & Revenues Top Estimates, Stock Up
Published: April 22, 2025 by: Zacks Investment Research
Sentiment: Positive
DGX delivers solid top-line growth in the first quarter of 2025.
Read More
Quest Diagnostics (DGX) Q1 Earnings and Revenues Beat Estimates
Published: April 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Quest Diagnostics (DGX) came out with quarterly earnings of $2.21 per share, beating the Zacks Consensus Estimate of $2.15 per share. This compares to earnings of $2.04 per share a year ago.
Read More
Quest beats quarterly profit estimates on strong demand for diagnostic tests
Published: April 22, 2025 by: Reuters
Sentiment: Positive
Laboratory operator Quest Diagnostics beat Wall Street estimates for first-quarter profit on Tuesday, helped by robust demand for its diagnostic tests.
Read More
8 Upcoming Dividend Increases During Volatile Times
Published: April 04, 2025 by: Seeking Alpha
Sentiment: Positive
8 Upcoming Dividend Increases During Volatile Times
Read More
DGX Stock Set to Benefit From New Google Cloud Partnership
Published: March 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Quest Diagnostics teams up with Google Cloud to streamline data and personalize customer experiences using gen AI.
Read More
Quest Diagnostics to Collaborate with Google Cloud to Streamline Data and Personalize Customer Experiences Using Generative AI
Published: March 18, 2025 by: PRNewsWire
Sentiment: Neutral
SUNNYVALE, Calif. and SECAUCUS, N.J.
Read More
Quest Diagnostics Stock Jumps 38% in a Year: What's Behind the Surge?
Published: March 03, 2025 by: Zacks Investment Research
Sentiment: Positive
DGX outperforms the industry and the S&P 500 composite's gain in the past year, driven by strong core performance and contributions from acquisitions.
Read More
Is it Apt to Hold Quest Diagnostics Stock in Your Portfolio Now?
Published: February 25, 2025 by: Zacks Investment Research
Sentiment: Positive
DGX stays on investors' radars due to its robust prospects in Advanced Diagnostics and progress in the acquisition strategy.
Read More
Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics
Published: February 24, 2025 by: PRNewsWire
Sentiment: Neutral
Quest to provide comprehensive dialysis-related laboratory and water testing services to Fresenius Medical Care owned and affiliated clinics in the United States BAD HOMBURG, Germany and SECAUCUS, N.J. , Feb. 24, 2025 /PRNewswire/ -- Fresenius Medical Care (XETRA: FME; NYSE: FMS), the world's leading provider of products and services for individuals with renal disease, and Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that, under terms of a definitive acquisition agreement, Quest will acquire select assets of FME's wholly owned Spectra Laboratories, a leading provider of renal-specific laboratory testing services in the U.S. In addition, …
Read More
Quest Diagnostics to Host Investor Day on March 19, 2025
Published: February 13, 2025 by: PRNewsWire
Sentiment: Neutral
SECAUCUS, N.J. , Feb. 13, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, will host an Investor Day for institutional investors and financial analysts in New York City on Thursday, March 19, 2025 at the New York Stock Exchange.
Read More
Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term
Published: February 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
About Quest Diagnostics Incorporated (DGX)
- IPO Date 1996-12-17
- Website https://www.questdiagnostics.com
- Industry Medical - Diagnostics & Research
- CEO Mr. James E. Davis
- Employees 55000